SORIATANE Side Effects

6930306-3 | Abdominal Distension, Cardiac Failure Congestive, Dyspnoea, Fluid Retention, Oedema Peripheral
on Aug 16, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, cardiac failure congestive, dyspnoea, fluid retention, oedema peripheral. Soriatane dosage: 25mg Per Day. During the same period patient was treated with APIDRA (View Apidra Review and Apidra Label ), LANTUS (View Lantus Review and Lantus Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZEMPLAR (View Zemplar Review and Zemplar Label ).

6814680-4 | Abortion Spontaneous
Patient was taking Soriatane (View Usage). Patient had the following side effects: abortion spontaneous on Jun 30, 2010 from UNITED STATES Additional patient health information: Female patient , 37 years of age, was diagnosed with contraception and. Soriatane dosage: . During the same period patient was treated with BIRTH CONTROL PILLS (View Birth Control Pills Review and Birth Control Pills Label ).

6726273-8 | Abdominal Distension, Cardiac Failure Congestive, Dyspnoea, Fluid Retention, Oedema Peripheral
Adverse event was reported on May 06, 2010 by a Male patient taking Soriatane (View Usage) (Dosage: 25mg Per Day) was diagnosed with psoriasis and. Location: UNITED STATES , 71 years of age, After Soriatane was administered, patient had the following side effects: abdominal distension, cardiac failure congestive, dyspnoea, fluid retention, oedema peripheral. During the same period patient was treated with APIDRA (View Apidra Review and Apidra Label ), LANTUS (View Lantus Review and Lantus Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZEMPLAR (View Zemplar Review and Zemplar Label ).

6716181-0 | Abdominal Pain Upper, Alopecia, Dry Eye, Foaming At Mouth, Neck Pain, Oesophageal Pain, Throat Irritation, Vomiting
on May 06, 2010 Female patient from UNITED STATES , weighting 183.0 lb, was diagnosed with eczema (What is eczema?) and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alopecia, dry eye, foaming at mouth, neck pain, oesophageal pain, throat irritation, vomiting. Soriatane dosage: Once Daily Po.


6692424-7 | Visual Acuity Reduced, Visual Impairment
on Apr 20, 2010 Male patient from UNITED STATES , 89 years of age, was diagnosed with squamous cell carcinoma and was treated with Soriatane (View Usage). Patient had the following side effects: visual acuity reduced, visual impairment. Soriatane dosage: .

6690498-0 | Chapped Lips, Chills, Dry Mouth, Dry Skin, Feeling Hot, Psoriasis
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: chapped lips, chills, dry mouth, dry skin, feeling hot, psoriasis on Apr 19, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25mg Per Day. During the same period patient was treated with LOVAZA (View Lovaza Review and Lovaza Label ).

6690496-7 | Chapped Lips, Chills, Dry Mouth, Dry Skin, Feeling Hot, Lip Dry, Psoriasis, Pyrexia
Adverse event was reported on Apr 19, 2010 by a Male patient taking Soriatane (View Usage) (Dosage: 25mg Per Day) was diagnosed with psoriasis and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: chapped lips, chills, dry mouth, dry skin, feeling hot, lip dry, psoriasis, pyrexia. During the same period patient was treated with LOVAZA (View Lovaza Review and Lovaza Label ).

6684991-4 | Chapped Lips, Chills, Dry Mouth, Dry Skin, Feeling Hot, Psoriasis
on Apr 13, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: chapped lips, chills, dry mouth, dry skin, feeling hot, psoriasis. Soriatane dosage: 25mg Per Day. During the same period patient was treated with LOVAZA (View Lovaza Review and Lovaza Label ).

6666073-0 | Renal Impairment
on Mar 26, 2010 Male patient from FRANCE , 82 years of age, was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: renal impairment. Soriatane dosage: 30mg Per Day.

6655854-5 | Chapped Lips, Chills, Dry Mouth, Lip Dry, Psoriasis, Pyrexia
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: chapped lips, chills, dry mouth, lip dry, psoriasis, pyrexia on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25mg Per Day. During the same period patient was treated with LOVAZA (View Lovaza Review and Lovaza Label ).

6644829-8 | Therapeutic Response Unexpected, Vaginal Discharge, Vaginal Haemorrhage
Adverse event was reported on Mar 12, 2010 by a Female patient taking Soriatane (View Usage) (Dosage: 10mg Per Day) was diagnosed with squamous cell carcinoma and. Location: UNITED STATES , 79 years of age, Patient had the following side effects: therapeutic response unexpected, vaginal discharge, vaginal haemorrhage. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LUMIGAN (View Lumigan Review and Lumigan Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM (View Calcium Review and Calcium Label ), VIT C (View Vit C Review and Vit C Label ).

6600136-0 | Blister, Condition Aggravated, Ichthyosis, Lip Dry, Pain, Product Quality Issue, Skin Disorder, Skin Exfoliation
on Feb 23, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with ichthyosis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: blister, condition aggravated, ichthyosis, lip dry, pain (What is pain?), product quality issue, skin disorder, skin exfoliation. Soriatane dosage: 125mg Twice Per Day. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TIZANIDINE (View Tizanidine Review and Tizanidine Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ).

6588715-0 | Lip Dry, Psoriasis
on Feb 16, 2010 Male patient from UNITED STATES , 52 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: lip dry, psoriasis. Soriatane dosage: .

6541971-7 | Cerebrovascular Accident
Patient was taking Soriatane (View Usage). Patient had the following side effects: cerebrovascular accident on Jan 15, 2010 from UNITED STATES Additional patient health information: Male patient , 38 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25mg Per Day. Patient was hospitalized.

6464666-7 | Cerebrovascular Accident
Adverse event was reported on Nov 24, 2009 by a Male patient taking Soriatane (View Usage) (Dosage: 25mg Per Day) was diagnosed with psoriasis and. Location: UNITED STATES , 38 years of age, After Soriatane was administered, patient had the following side effects: cerebrovascular accident. Patient was hospitalized.

6457745-1 | Non-hodgkin's Lymphoma
on Nov 06, 2009 Male patient from DENMARK , 57 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: non-hodgkin's lymphoma. Soriatane dosage: 20 Mg;qd;po;po. During the same period patient was treated with METHOTREXATE (15 Mg;qd;po) (View Methotrexate Review and Methotrexate Label ), RAPTIVA (1 Mg/kg/qw;sc) (View Raptiva Review and Raptiva Label ).

6442272-8 | Onychomadesis
on Oct 12, 2009 Male patient from FRANCE , 39 years of age, was diagnosed with pustular psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: onychomadesis. Soriatane dosage: 30 Mg Milligram(s), Dosage(s)= 1interval=1 Day(s); Oral.

6430113-4 | Pregnancy With Contraceptive Device, Twin Pregnancy
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: pregnancy with contraceptive device, twin pregnancy on Oct 28, 2009 from UNITED STATES Additional patient health information: Female patient , 36 years of age, was diagnosed with psoriasis and. Soriatane dosage: 10 Mg; Po.

6409471-2 | Grand Mal Convulsion
Adverse event was reported on Oct 07, 2009 by a Male patient taking Soriatane (View Usage) (Dosage: Qd; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 38 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: grand mal convulsion. During the same period patient was treated with FINASTERIDE (View Finasteride Review and Finasteride Label ).

6399220-9 | Eczema, Eosinophilia, Haemoglobin Decreased, Skin Fissures, Toxic Skin Eruption, Wound Secretion
on Sep 25, 2009 Female patient from DENMARK , 77 years of age, was diagnosed with seborrhoea and was treated with Soriatane (View Usage). Patient had the following side effects: eczema (What is eczema?), eosinophilia, haemoglobin decreased, skin fissures, toxic skin eruption, wound secretion. Soriatane dosage: 25 Mg;qd; Po. During the same period patient was treated with BUFLOMEDIL (BUFLOMEDIL) (View Buflomedil (buflomedil) Review and Buflomedil (buflomedil) Label ), SELOKEN (View Seloken Review and Seloken Label ), EFFEXOR (View Effexor Review and Effexor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), HUMALOG (View Humalog Review and Humalog Label ), HUMAJECT 1 (View Humaject 1 Review and Humaject 1 Label ). Patient was hospitalized.

6369305-1 | Abortion, Pregnancy, Spina Bifida
on Sep 03, 2009 Female patient from DENMARK , 41 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: abortion (What is abortion?), pregnancy (What is pregnancy?), spina bifida (What is spina bifida?). Soriatane dosage: Qd; Po. During the same period patient was treated with PSORALEN (View Psoralen Review and Psoralen Label ), TRIPHASIL 21 (View Triphasil-21 Review and Triphasil-21 Label ). Patient was hospitalized.

6368649-7 | Lip Exfoliation, Movement Disorder, Oral Mucosal Exfoliation, Pain In Extremity, Pruritus, Skin Exfoliation
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: lip exfoliation, movement disorder (What is movement disorder?), oral mucosal exfoliation, pain in extremity, pruritus, skin exfoliation on Sep 17, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with psoriasis and. Soriatane dosage: 1 Capule Once Daily Oral.

6358993-1 | Abortion Induced, Pregnancy
Adverse event was reported on Aug 27, 2009 by a Female patient taking Soriatane (View Usage) (Dosage: Po) was diagnosed with psoriasis and. Location: DENMARK , 37 years of age, Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). During the same period patient was treated with METHOXSALEN (10 Mg; Qd) (View Methoxsalen Review and Methoxsalen Label ). Patient was hospitalized.

6358992-X | Abortion Induced, Hydrocephalus, Spina Bifida, Talipes
on Aug 27, 2009 Female patient from DENMARK , weighting 2.65 lb, was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: abortion induced, hydrocephalus (What is hydrocephalus?), spina bifida (What is spina bifida?), talipes. Soriatane dosage: Trpl. During the same period patient was treated with METHOXSALEN (Trpl) (View Methoxsalen Review and Methoxsalen Label ).

6342204-7 | Deafness
on Sep 03, 2009 Male patient from UNITED STATES , weighting 230.0 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Soriatane dosage: 25mg 1 Per Day Po.

6268221-3 | Condition Aggravated, Pruritus, Rash, Skin Exfoliation
Patient was taking Soriatane (View Usage). Patient had the following side effects: condition aggravated, pruritus, rash (What is rash?), skin exfoliation on Jul 14, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 128.0 lb, . Soriatane dosage: .

6248967-3 | Diabetes Mellitus
Adverse event was reported on Jun 18, 2009 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg; Qd; Po) . Location: UNITED STATES , 58 years of age, After Soriatane was administered, patient had the following side effects: diabetes mellitus. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ).

6212934-6 | Alopecia, Back Pain, Blood Glucose Increased, Cellulitis, Chapped Lips, Diabetes Mellitus, Dry Eye, Gait Disturbance, Migraine
on May 19, 2009 Female patient from UNITED STATES , 50 years of age, weighting 184.0 lb, was diagnosed with mycosis fungoides and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, back pain (What is back pain?), blood glucose increased, cellulitis (What is cellulitis?), chapped lips, diabetes mellitus, dry eye, gait disturbance, migraine (What is migraine?). Soriatane dosage: 25 Mg; Qd; Po. During the same period patient was treated with TEKTURNA (View Tekturna Review and Tekturna Label ), PLAVIX (View Plavix Review and Plavix Label ).

6198256-0 | Dyspnoea, Erythema, Off Label Use, Pulmonary Congestion
on May 11, 2009 Male patient from UNITED STATES , 72 years of age, weighting 205.0 lb, was diagnosed with dermatitis and was treated with Soriatane (View Usage). Patient had the following side effects: dyspnoea, erythema, off label use, pulmonary congestion. Soriatane dosage: 10 Mg; X1; Po. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6168579-X | Abortion Induced, Alcohol Use, Photosensitivity Reaction, Pregnancy, Staphylococcal Infection
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: abortion induced, alcohol use, photosensitivity reaction, pregnancy (What is pregnancy?), staphylococcal infection (What is staphylococcal infection?) on Apr 15, 2009 from UNITED STATES Additional patient health information: Female patient , 26 years of age, was diagnosed with psoriasis and. Soriatane dosage: 10 Mg;qd;po. During the same period patient was treated with ALCOHOL (X1) (View Alcohol Review and Alcohol Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ).

6161639-9 | Alopecia, Blood Pressure Increased, Gait Disturbance, Localised Infection, Off Label Use, Skin Exfoliation, Skin Haemorrhage, Visual Impairment
Adverse event was reported on Apr 08, 2009 by a Male patient taking Soriatane (View Usage) (Dosage: 25 Mg;qod;po) was diagnosed with pityriasis rubra pilaris, depression (What is depression?) and. Location: UNITED STATES , 72 years of age, weighting 192.0 lb, Patient experienced the following unwanted or unexpected effects: alopecia, blood pressure increased, gait disturbance, localised infection, off label use, skin exfoliation, skin haemorrhage, visual impairment. During the same period patient was treated with DOXEPIN HCL (10 Mg;qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), AMBIEN (View Ambien Review and Ambien Label ).

6153773-4 | Clostridium Difficile Colitis, Pain In Extremity, Peptic Ulcer
on Apr 02, 2009 Female patient from UNITED STATES , 62 years of age, weighting 195.0 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: clostridium difficile colitis, pain in extremity, peptic ulcer (What is peptic ulcer?). Soriatane dosage: 10 Mg; Qd; Po. During the same period patient was treated with HUMIRA (40 Mg; Qow; Sc) (View Humira Review and Humira Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6153772-2 | Alcohol Use, Photosensitivity Reaction, Pregnancy, Staphylococcal Infection, Treatment Noncompliance
on Apr 02, 2009 Female patient from UNITED STATES , 26 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: alcohol use, photosensitivity reaction, pregnancy (What is pregnancy?), staphylococcal infection (What is staphylococcal infection?), treatment noncompliance. Soriatane dosage: 10 Mg, Qd, Po. During the same period patient was treated with ALCOHOL (X1) (View Alcohol Review and Alcohol Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ).

6149639-6 | Pregnancy
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?) on Mar 04, 2009 from FRANCE Additional patient health information: Female patient , 41 years of age, was diagnosed with psoriasis and. Soriatane dosage: 10 Mg Milligram(s) Dosage(s)=1 Interval=1 Day(s) Oral.

6138974-3 | Photosensitivity Reaction, Pregnancy, Staphylococcal Infection, Treatment Noncompliance
Adverse event was reported on Mar 19, 2009 by a Female patient taking Soriatane (View Usage) (Dosage: 10 Mg;qd;po) was diagnosed with psoriasis and. Location: UNITED STATES , 26 years of age, Patient had the following side effects: photosensitivity reaction, pregnancy (What is pregnancy?), staphylococcal infection (What is staphylococcal infection?), treatment noncompliance. During the same period patient was treated with ALCOHOL (X1) (View Alcohol Review and Alcohol Label ), BIRTH CONTROL PILLS (View Birth Control Pills Review and Birth Control Pills Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ).

6130495-7 | Treatment Noncompliance
on Mar 10, 2009 Male patient from UNITED STATES , 26 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: treatment noncompliance. Soriatane dosage: 10 Mg; Qd; Po. During the same period patient was treated with ALCOHOL (X1) (View Alcohol Review and Alcohol Label ), BIRTH CONTROL PILLS (View Birth Control Pills Review and Birth Control Pills Label ).

6115786-8 | Blood Parathyroid Hormone Decreased, Blood Parathyroid Hormone Increased
on Mar 02, 2009 Female patient from UNITED STATES , 55 years of age, was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: blood parathyroid hormone decreased, blood parathyroid hormone increased. Soriatane dosage: 20 Mg, Qod, Po.

6113136-4 | Coronary Artery Stenosis, Hypotension, Myocardial Infarction
Patient was taking Soriatane (View Usage). Patient had the following side effects: coronary artery stenosis, hypotension, myocardial infarction on Mar 05, 2009 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 149.9 lb, was diagnosed with psoriasis and. Soriatane dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), ZETIA (View Zetia Review and Zetia Label ). Patient was hospitalized.

6109544-8 | Cardiomyopathy, Neuropathy Peripheral, Off Label Use
Adverse event was reported on Feb 25, 2009 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg; Qd; Po) was diagnosed with hyperkeratosis and. Location: UNITED STATES , 21 years of age, After Soriatane was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), neuropathy peripheral, off label use.

6108918-9 | Abortion Induced, Treatment Noncompliance, Twin Pregnancy
on Feb 24, 2009 Female patient from DENMARK , 30 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, treatment noncompliance, twin pregnancy. Soriatane dosage: 35 Mg;qd;po : 25 Mg;qd;po.

6076453-2 | Blood Parathyroid Hormone Decreased, Blood Parathyroid Hormone Increased
on Feb 05, 2009 Female patient from UNITED STATES , 55 years of age, was treated with Soriatane (View Usage). Patient had the following side effects: blood parathyroid hormone decreased, blood parathyroid hormone increased. Soriatane dosage: 20 Mg;qod;po.

6056051-7 | Alopecia, Bone Pain, Constipation, Diabetes Mellitus, Diabetic Ketoacidosis, Disturbance In Attention, Headache, Intermittent Claudication, Lethargy
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: alopecia, bone pain, constipation (What is constipation?), diabetes mellitus, diabetic ketoacidosis, disturbance in attention, headache (What is headache?), intermittent claudication, lethargy on Nov 19, 2008 from CANADA Additional patient health information: Male patient , 37 years of age, was diagnosed with psoriasis and. Soriatane dosage: 10 Mg 1 Time Pr. Day Oral. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6036425-0 | Oesophageal Haemorrhage, Vomiting
Adverse event was reported on Jan 05, 2009 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg;biw;po) was diagnosed with psoriasis and. Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: oesophageal haemorrhage, vomiting. Patient was hospitalized.

6028664-X | Abortion Induced, Pregnancy
on Dec 12, 2008 Female patient from DENMARK , 26 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). Soriatane dosage: Po. Patient was hospitalized.

6027103-2 | Alopecia
on Jan 02, 2009 Female patient from UNITED STATES , 70 years of age, weighting 135.0 lb, was diagnosed with skin papilloma and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: alopecia. Soriatane dosage: 25 Mg Daily Po.

6016181-2 | Suicide Attempt
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: suicide attempt on Dec 08, 2008 from UNITED STATES Additional patient health information: Male patient , 17 years of age, weighting 116.8 lb, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg;qd;po, 25 Mg;qd;po, 50 Mg;qd;po, 25 Mg;qd;po, 50 Mg;qd;po. During the same period patient was treated with TACLONEX (;qd;) (View Taclonex Review and Taclonex Label ), DOVONEX (View Dovonex Review and Dovonex Label ).

6002622-3 | Coronary Artery Stenosis, Epistaxis, Hypotension, Myocardial Infarction, Weight Decreased
Adverse event was reported on Dec 01, 2008 by a Male patient taking Soriatane (View Usage) (Dosage: 25 Mg, Qd; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 49 years of age, weighting 150.0 lb, Patient had the following side effects: coronary artery stenosis, epistaxis, hypotension, myocardial infarction, weight decreased. During the same period patient was treated with ADVAIR DISKUS 250/50 (1 Df, Bid;) (View Advair Diskus 250/50 Review and Advair Diskus 250/50 Label ), SINGULAIR (10 Mg; Qd;) (View Singulair Review and Singulair Label ), TRICOR (145 Mg;) (View Tricor Review and Tricor Label ), ASPIRIN (325 Mg; Qd) (View Aspirin Review and Aspirin Label ), LIPITOR (40 Mg; Hs;) (View Lipitor Review and Lipitor Label ), PLAVIX (75 Mg; Qd) (View Plavix Review and Plavix Label ), METOPROLOL (12.5 Mg;) (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

5999185-5 | Dry Skin, Erythema, Lip Dry, Pain In Extremity, Pulmonary Embolism, Pulmonary Thrombosis, Tendon Disorder
on Dec 01, 2008 Female patient from UNITED STATES , 55 years of age, weighting 222.0 lb, was diagnosed with psoriasis, depression (What is depression?), insomnia and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: dry skin, erythema, lip dry, pain in extremity, pulmonary embolism (What is pulmonary embolism?), pulmonary thrombosis, tendon disorder. Soriatane dosage: 25 Mg; Bid; Po. During the same period patient was treated with PREMPRO (Qd; Po) (View Prempro Review and Prempro Label ), ZOLOFT (50 Mg; Qd; Po) (View Zoloft Review and Zoloft Label ), ELAVIL (10 Mg; Qd) (View Elavil Review and Elavil Label ). Patient was hospitalized.

5990011-7 | Deafness Unilateral, Tinnitus
on Dec 09, 2008 Male patient from UNITED STATES , 77 years of age, weighting 180.0 lb, was diagnosed with porokeratosis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: deafness unilateral, tinnitus (What is tinnitus?). Soriatane dosage: 25 Mg Daily Po.

5960865-9 | Abortion Induced, Pregnancy
Patient was taking Soriatane (View Usage). Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?) on Nov 03, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 26 years of age, was diagnosed with psoriasis and. Soriatane dosage: Po. During the same period patient was treated with BETNEVAL (BETAMETHASONE VALRATE) /00008503/ (View Betneval (betamethasone Valrate) /00008503/ Review and Betneval (betamethasone Valrate) /00008503/ Label ), DERMOVAL /00337102/ (CLOBETASOL PROPIONATE) (View Dermoval /00337102/ (clobetasol Propionate) Review and Dermoval /00337102/ (clobetasol Propionate) Label ), DESONIDE (View Desonide Review and Desonide Label ).